We are live on ! Find out more
LCG

Lisanti Capital Growth Portfolio holdings

AUM $397M
1-Year Est. Return 178.66%
This Fund
S&P 500
This Quarter Est. Return
+22.31%
1 Year Est. Return
+178.66%
3 Year Est. Return
+1,089.72%
5 Year Est. Return
+3,176.57%
10 Year Est. Return
+120,936.2%
AUM
$377M
AUM Growth
+$70.4M
Cap. Flow
+$26.2M
Cap. Flow %
6.95%
Top 10 Hldgs %
20.2%
Holding
148
New
51
Increased
39
Reduced
23
Closed
35

Top Buys

Rank Stock Value
1
AMED
Amedisys
AMED
+$7.29M
2
WGO icon
Winnebago Industries
WGO
+$6.66M
3
VIAV icon
Viavi Solutions
VIAV
+$6.24M
4
STAA icon
STAAR Surgical
STAA
+$5.9M
5
FFIN icon
First Financial Bankshares
FFIN
+$5.36M

Top Sells

Rank Stock Value
1
MRCY icon
Mercury Systems
MRCY
+$9.02M
2
SLAB icon
Silicon Laboratories
SLAB
+$6.96M
3
HAE icon
Haemonetics
HAE
+$6.73M
4
AIN icon
Albany International
AIN
+$5.96M
5
LGIH icon
LGI Homes
LGIH
+$5.96M

Sector Composition

Rank Sector Weight
1 Healthcare 25.53%
2 Technology 23.63%
3 Consumer Discretionary 17.44%
4 Industrials 15.68%
5 Financials 4.2%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
FND icon
101
Floor & Decor
FND
$6.08B
$1.08M 0.29%
21,171
-16,399
-44% -$768K
BFAM icon
102
Bright Horizons
BFAM
$4.01B
$1.03M 0.27%
6,882
-5,918
-46% -$888K
HEI icon
103
HEICO Corp
HEI
$50.4B
$965K 0.26%
8,455
-12,566
-60% -$1.55M
BHVN
104
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$816K 0.22%
+14,990
New +$742K
PLMR icon
105
Palomar
PLMR
$3.62B
$757K 0.2%
+14,985
New +$702K
SIBN icon
106
SI-BONE Inc
SIBN
$818M
$729K 0.19%
+33,915
New +$608K
PTON icon
107
Peloton Interactive
PTON
$2.79B
$662K 0.18%
+23,299
New +$628K
ARWR icon
108
Arrowhead Research
ARWR
$12.1B
$648K 0.17%
+10,215
New +$507K
ALNY icon
109
Alnylam Pharmaceuticals
ALNY
$29.5B
$587K 0.16%
+5,095
New +$508K
CRSP icon
110
CRISPR Therapeutics
CRSP
$4.88B
$580K 0.15%
+9,515
New +$520K
COUP
111
DELISTED
Coupa Software Incorporated
COUP
$572K 0.15%
3,908
-32,272
-89% -$4.61M
TXRH icon
112
Texas Roadhouse
TXRH
$13.8B
$530K 0.14%
+9,409
New +$517K
RCKT icon
113
Rocket Pharmaceuticals
RCKT
$372M
$278K 0.07%
+12,220
New +$204K
AIN icon
114
Albany International
AIN
$2.13B
– –
-66,150
Closed -$5.96M
COHR icon
115
Coherent
COHR
$56.4B
– –
-56,620
Closed -$1.99M
ELF icon
116
e.l.f. Beauty
ELF
$4.87B
– –
-143,395
Closed -$2.51M
FATE icon
117
Fate Therapeutics
FATE
$291M
– –
-125,060
Closed -$1.94M
FTDR icon
118
Frontdoor
FTDR
$5.34B
– –
-116,120
Closed -$5.64M
GH icon
119
Guardant Health
GH
$21.3B
– –
-19,270
Closed -$1.23M
GO icon
120
Grocery Outlet
GO
$964M
– –
-44,730
Closed -$1.55M
GTLS
121
DELISTED
Chart Industries
GTLS
– –
-34,650
Closed -$2.16M
HAE icon
122
Haemonetics
HAE
$3.94B
– –
-53,385
Closed -$6.73M
HXL icon
123
Hexcel
HXL
$7.73B
– –
-23,495
Closed -$1.93M
KNX icon
124
Knight Transportation
KNX
$11.1B
– –
-93,940
Closed -$3.41M
LGIH icon
125
LGI Homes
LGIH
$1.3B
– –
-71,530
Closed -$5.96M
2 3 4
5
6

Similar funds

GF
Gray Foundation Cohoes, New York $397M AUM 32.69% 1-Year Est. Return
PIM
Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return
EH
EMG Holdings Old Greenwich, Connecticut $397M AUM 9.97% 1-Year Est. Return
TPWA
Twin Peaks Wealth Advisors Burlingame, California $397M AUM 23.23% 1-Year Est. Return
STT
Singapore Technologies Telemedia Singapore $396M AUM 59.06% 1-Year Est. Return
VC
Vision Capital Toronto, Ontario, Canada $397M AUM 0.8% 1-Year Est. Return
CF
Cypress Funds Los Angeles, California $398M AUM 8.77% 1-Year Est. Return
IVLAV
Index Venture Life Associates VI St. Helier, Jersey $396M AUM 176.22% 1-Year Est. Return

Lisanti Capital Growth's Q4 2019 Portfolio in Review

As of Q4 2019, Lisanti Capital Growth held 148 positions worth $377M, up 23% from $307M the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Lisanti Capital Growth deployed $26.2M of net new capital in Q4 2019, opening 51 new positions and adding to 39 existing holdings. Its largest new stake was Amedisys: 48,997 shares worth $8.18M.

By sector, the portfolio is most concentrated in Healthcare at 26% of assets, up from 17% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was TopBuild, an estimated $5.44M trimmed.

  • Lisanti Capital Growth's largest Q4 2019 buy was Amedisys: 48,997 shares worth $8.18M.
  • Lisanti Capital Growth added most to Planet Fitness in Q4 2019, an estimated $4.19M increase.
  • Lisanti Capital Growth's biggest Q4 2019 reduction was TopBuild, cutting an estimated $5.44M.
  • Lisanti Capital Growth fully exited Mercury Systems in Q4 2019, selling an estimated $9.02M.
  • Lisanti Capital Growth's ten largest holdings make up 20% of its $377M portfolio in Q4 2019.
  • Lisanti Capital Growth opened 51 new positions and closed 35 in Q4 2019.
  • Lisanti Capital Growth's portfolio value rose 23% quarter-over-quarter to $377M.

Based on Lisanti Capital Growth's 13F filing for Q4 2019, filed 13 Feb 2020.